ContractAmendment Agreement to the Acquisition Option • October 31st, 2016 • Oculus Innovative Sciences, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 31st, 2016 Company IndustryAMENDMENT AGREEMENT TO THE ACQUISITION OPTION (THE “AMENDMENT AGREEMENT”), ENTRED INTO BY AND BETWEEN MORE PHARMA CORPORATION, S. DE R.L. DE C.V., REPRESENTED BY MR. RICARDO GUILLERMO AMTMANN AGUILAR, HERINAFTER REFERRED TO AS “MORE PHARMA”, AND OCULUS TECHNOLOGIES OF MEXICO, S.A. DE C.V., REPRESENTED BY MR. EVERARDO GARIBAY RAMÍREZ, HEREINAFTER REFERRED TO AS “OTM”, IN ACCORDANCE WITH THE FOLLOWING BACKGROUND, WHEREAS AND CLAUSES.